{{Rsnum
|rsid=2270992
|Gene=PTPRJ
|Chromosome=11
|position=48123695
|Orientation=minus
|GMAF=0.4949
|Gene_s=PTPRJ
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 12.7 | 57.1 | 30.2
| HCB | 11.1 | 44.4 | 44.4
| JPT | 18.2 | 54.5 | 27.3
| YRI | 85.5 | 14.5 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 11.1 | 44.4 | 44.4
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23341091
|Title=High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to non-hodgkin's lymphoma
}}

{{on chip | FTDNA}}